Epclusa Price in India: A Comprehensive Guide
Epclusa price in India might surprise many. Ever wondered how such a crucial medication can be so affordable?
Doubts might arise, questioning its authenticity. Is it genuine or a knockoff?
Dive deeper as we answer your most pressing questions about the Epclusa price in India.
Regarded as a universal treatment, Epclusa is pivotal in treating all genotypes of hepatitis C.
The stark difference between the Epclusa cost in India at $699 and the US price tag of about $78,078 is astounding.
Designed to treat hepatitis C genotypes 1 through 6, it follows its predecessors, Harvoni and Sovaldi. A simple once-daily oral tablet for 84 days usually does the trick for most HCV patients.
Worryingly, an estimated 77% of hep C diagnosed individuals forgo treatment. If you belong to this group, the Indian price offers an affordable path to recovery.
Imagine feeling rejuvenated, all for a fraction of the cost elsewhere!
Who Benefits from Epclusa?
Predominantly, those afflicted with hepatitis C. Generic Epclusa, notably the first to treat genotypes 2 and 3 sans ribavirin for most, boasts an impressive 94% to 99% success rate across all genotypes.
Is hep C sexually transmitted? Although not primarily an STD, transmission via sexual contact is uncommon. More prevalent is the transmission through shared needles and drug-related equipment.
The Genesis of Generic Epclusa price in India:
Asegua Therapeutics, under Gilead Sciences, introduced generic Epclusa, christened sofosbuvir velpatasvir. These compounds are Epclusa’s active ingredients.
Interestingly, Indian pharmaceutical giants like Hetero Drugs, Natco, and Cipla are behind its manufacturing, aligning with DAAs guidelines, a revolutionary hep C treatment approach.
Diving into Generic Epclusa Brands:
Apart from sofosbuvir velpatasvir, several generic Epclusa brand names hail from India. Velpanat from Natco remains the top pick. Other notable Indian brands like Cipla, Mylan, and Dr. Reddys also produce these tablets. A 12-week regimen, totaling 84 tablets, usually ensures recovery for most US genotype patients.
Price Insights:
Without insurance, Epclusa fetches around $78,078 for a 12-week course. However, the generic version from Asegua Therapeutics is priced significantly lower at approximately $24,000 for the same duration. Given its efficacy, the Epclusa cost in India at $699 for the complete treatment is a game-changer.
Comparing Harvoni and Epclusa:
While Harvoni comprises ledipasvir and sofosbuvir, Epclusa has velpatasvir and sofosbuvir. Both serve distinct hep C genotypes, with Epclusa offering a broader spectrum of treatment.
Is there a Harvoni generic? Yes, named ledipasvir sofosbuvir, and priced at $24,000 for 84 days.
Medicare’s Stand on Epclusa:
Medicare or Medicaid covers a chunk of Epclusa’s cost, usually around 25% for eligible enrollees. The savings can be significant, especially when compared to Gilead Sciences’ brand price tag. You can check out this non profit, they maybe able to help as well.
Behind Epclusa Price in India:
Gilead Sciences, the company behind Epclusa, launched it in the US on June 28th, 2016. This came post its FDA approval for treating hep C genotypes 1 to 6. There are other sources for hep C treatments you can review here.
Treatment Insights:
Depending on the hepatitis C viral load, a doctor might recommend holding off treatment due to the associated costs. However, it’s paramount not to be disheartened.
Whether it’s Epclusa, its generic version, or other Indian generics, keep pushing for a cure. Numerous support systems, including co-pay programs and Patient Assistance Programs, can help.
India’s Hepatitis C Treatment Landscape:
Licensed under Gilead Sciences and FDA’s watch, generic versions of Harvoni, Sovaldi, and Epclusa in India are a beacon of affordability. The Epclusa price in India stands out, offering an entire treatment course for just $699.
Act Now!:
Why wait when a cure awaits? Rediscover life without the debilitating effects of hep C. With the Epclusa price in India, reclaim your health without burning a hole in your pocket.
All generic versions of Harvoni , Sovaldi and Epclusa are manufactured under the license of Gilead Sciences and the FDA.
Please visit this link to the FDA office in India, they license and authorize the manufacturing of hepatitis C treatments.
Epclusa cost in India is a fraction of the price you will pay even if you do have insurance.
Affordable hepatitis C treatment with a 100% Money Back Guarantee
Epclusa cost in India is only $699 for 84 tablets, 12 weeks treatment.
Harvoni cost in India is also $499 for 84 tablets, 12 weeks treatment.
Sovaldi cost in India is $399 for 84 tablets, 12 weeks treatment.
Sovaldi and Daklinza cost in India is $599 for 12 weeks treatment.
All hepatitis C treatments come with a money back guarantee if you are not cured.
Limited Time Offer
Don’t delay, get cured, your liver, body and mind will thank you for it.
You can finally say BYE BYE to those days of nasty brain fog!